Paul Hazen is a Dermatology physician affiliated with University Hospitals of Cleveland. OpenAlex indexes 59 publications with 2,192 citations (h-index 22).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2205 Crocker Rd Ste 109
Westlake, OH 441456710
Telephone
440-482-8323Provider last certified this registry record 29 Aug 2024.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year202516 payments
- Novartis Pharmaceuticals CorporationProgram year20257 payments
- Lilly USA, LLCProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
73.3%Tetracycline-class Drug28.5%Doxycycline Hyclate67%Minocycline Hcl33%Part D<11 patientsLincosamide Antibacterial14.9%Clindamycin Hcl67%Clindamycin Phosphate33%Part D<11 patients+ 3 more classes in this area
Cancer & immunology
10.9%TNF inhibitor10.9%Inflectra54%Humira(Cf) Pen46%Part D<11 patientsDermatology
10.4%Corticosteroid10.4%Triamcinolone Acetonide100%Part D≥14 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus
Journal of the American Academy of Dermatology
2025 - 64392 Patient and Dermatologists Perspectives on Hidradenitis Suppurativa Draining Tunnel Treatment and Unmet Needs
Journal of the American Academy of Dermatology
2025 - North American clinical management guidelines for hidradenitis suppurativa: A publication from the United States and Canadian Hidradenitis Suppurativa Foundations
Journal of the American Academy of Dermatology
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Michael Lederman, MD
University Hospitals of Cleveland
Anthony Furlan
University Hospitals of Cleveland
Joseph Sabik, MD
University Hospitals of Cleveland
Hans Luders
University Hospitals of Cleveland
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”